Key result
Quercetin significantly inhibited histone-induced red blood cell aggregation, eryptosis, and hemolysis, highlighting its therapeutic potential in histone-associated pathological conditions.
Why the study?
Cell-free histones induce RBC dysfunction and toxicity in histone-associated disorders, but the underlying mechanism and potential protective strategies remained to be understood.
Does quercetin prevent red blood cell aggregation, eryptosis, and hemolysis induced by cell-free histones?
Does quercetin prevent red blood cell aggregation, eryptosis, and hemolysis induced by cell-free histones?
Quercetin protects red blood cells from histone-induced aggregation, eryptosis, and hemolysis, highlighting its potential therapeutic value in histone-associated pathological conditions.
Answers are grounded in this paper and cite their sources.
Quercetin may mitigate histone-induced RBC injury in animals; leaves open clinical translation in histone-associated conditions.
Histones are nuclear proteins and play a vital role in regulating gene expression. Cell free histones in the circulation proved as damage-associated molecular patterns and were positively associated with various inflammatory disease conditions. Also, cell-free histones directly induce toxicity toward blood cells and are implicated in vascular dysfunction. However, cell-free histones are known to induce RBCs dysfunction in several histone-associated disorders, leading to hypoxia conditions. In this study, we aimed to understand the mechanism underlying the dysfunction of RBCs induced by histones and explore the protective effect of quercetin. Histone treatment at lower doses induces RBCs aggregation while at higher doses it induces eryptosis and delayed hemolysis. Surprisingly, the removal of negatively charged sialic acid on the RBC membrane prevents histone-induced toxicity, thereby confirming the significance of the interaction between sialic acid and histone. Quercetin (QUE), a flavonoid, significantly inhibits histone-induced RBCs aggregation, eryptosis, and hemolysis. Most importantly, inhibition against the pro-coagulant phenotype of RBCs induced by histones, emphasizes the therapeutic potential of QUE on blood coagulation. Further, spectral and molecular docking studies confirm the interaction between histones and QUE. Collectively, this study highlights the therapeutic value of QUE in protecting the RBCs functions during histones-associated pathological conditions.
No takes yet. Share an insight, caveat, or question.
Manikanta et al. (2025) studied Histone-associated RBC dysfunction. Quercetin vs. Histone treatment alone was evaluated on RBC aggregation, eryptosis, and hemolysis. Quercetin significantly inhibited histone-induced red blood cell aggregation, eryptosis, and hemolysis, highlighting its therapeutic potential in histone-associated pathological conditions.
Synapse has enriched 10 related papers. Consider them for comparative context: